FDA Inspection 1304198 — Yueming Song, MD
The FDA completed an inspection of Yueming Song, MD on Feb 6, 2026 in Chengdu. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 6, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Chengdu (China)
Additional Details
Clinical Investigator (CI)